PLA2R1 and Autoimmunity: Indeed, although initial serum samples were taken at the time of kidney biopsy before immunosuppressive treatment, sensitivity of detection of PLA2R autoimmunity rose from 77.8% using serology to 89.6% using a combination of PLA2R-Ab assessment in serum and PLA2R-Ag detection in kidney biopsy.